Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
The behavioral health sector experienced significant Medicaid funding clawbacks in federal fiscal year 2021, as revealed in a recent report from the Office of...
The United States is grappling with a worsening addiction and overdose epidemic—one that has claimed more than 105,000 lives in a recent 12-month period—highlighting...
Intellectual and developmental disabilities (I/DD) services have long faced significant challenges, particularly regarding reimbursement and workforce stability. A recent report released jointly by the...
In a pivotal move to tackle America’s overdose epidemic, the U.S. Department of Health and Human Services (HHS) has announced $25.6 million in federal...
Substance use disorders (SUDs) continue to present significant challenges across the healthcare landscape. Traditional treatment methods, while helpful for many, have not always succeeded...